P2X7 polymorphism and chronic lymphocytic leukaemia [9] (multiple letters)

Lancet

Volumn 361, Issue 9367, 2003, Pages 1478-1479

  Mitsiades, Constantine S ^a   Mitsiades, Nicholas ^a   Thunberg, Ulf ^b   Tobin, Gerard ^b   Johnson, Anna ^b   Enblad, Gunilla ^b   Rosenquist, Richard ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CYTOGENETICS; DISEASE MARKER; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC POLYMORPHISM; HUMAN; IMMUNOPHENOTYPING; LETTER; MOLECULAR GENETICS; MUTATION; PRIORITY JOURNAL; PROGNOSIS; GENETICS; MORTALITY; NOTE;

PURINE P2 RECEPTOR; PURINE P2X7 RECEPTOR;

HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, PURINERGIC P2;

EID: 0037467506     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13125-X     Document Type: Letter

References (5)

1. U Thunberg G Tobin A Johnson Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia Lancet 360 2002 1935 1939
2. A Krober T Seiler A Benner V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia Blood 100 2002 1410 1416
3. DG Oscier AC Gardiner SJ Mould Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors Blood 100 2002 1177 1184
4. M Ritgen A Lange S Stilgenbauer Unmutated immunoglobulin variable heavy chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia Blood 2002 (DOI 10.1182/blood-2002-06-1744) published online Oct 31, 2002
5. A Rosenwald AA Alizadeh G Widhopf Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia J Exp Med 194 2001 1639 1647